Psychedelics and Ketamine: Molecular Mechanisms Behind Long-Lasting Neuromodulation

This research delves into the epigenetic mechanisms through which classical psychedelics, such as psilocybin and LSD, and ketamine exert their long-lasting neuromodulatory effects. The study focuses on how these substances interact with the brain at a molecular level to induce enduring changes in neural function. Specifically, it examines the role of epigenetics, which involves modifications to DNA that alter gene expression without changing the underlying DNA sequence. These epigenetic changes are hypothesized to underlie the sustained therapeutic benefits observed in conditions like depression and anxiety following psychedelic-assisted therapy. The research explores how psychedelics might reset gene expression patterns in neurons, potentially reversing detrimental changes associated with chronic stress or mental illness. Understanding these molecular pathways is crucial for developing more targeted and effective psychedelic-based treatments. The investigation highlights the potential for these compounds to promote neuroplasticity, a key factor in recovery and adaptation of the brain. By modulating epigenetic landscapes, psychedelics and ketamine may offer a novel approach to treating a range of neurological and psychiatric disorders. This work lays the groundwork for future clinical applications and further scientific inquiry into the complex interplay between genetics, epigenetics, and mental health.